SAN ANTONIO -- Preoperative radiotherapy (RT) plus PD-1 inhibitor pembrolizumab (Keytruda) significantly increased immune ...

Like everything in health policy, it's complicated.

"What you have said is a terrible, terrible distortion of all the facts." -- CDC Advisory Committee on Immunization Practices ...

Today, we confront emerging threats from a range of respiratory viruses, insect-transmitted viruses, and viruses we have not ...

Kotsopoulos noted that BRCA carriers have a substantially increased lifetime risk of breast and ovarian cancer. Management of ...

Use of the dual GIP/GLP-1 drug tirzepatide (Mounjaro, Zepbound) was associated with a significantly reduced risk of glaucoma ...

The final Dec. 5 memo, according to FDA employees with knowledge of the situation, states that under an established World ...

The FDA on Thursday approved a transcranial direct current stimulation (tDCS) device as the first at-home non-drug therapy ...

In May 2018, andexanet was granted accelerated approval as the sole antidote on the market for the DOACs rivaroxaban (Xarelto ...

True or False: A large observational study found that adults with diabetes who used GLP-1 receptor agonists had more ...

Sources tell CNN the FDA is planning to slap a black boxed warning on COVID vaccines -- the agency's most serious warning ...

GLP-1 receptor agonists were tied to a 16% lower risk of epilepsy in adults with type 2 diabetes. Epilepsy is an ...